T 0764/06 (Crystalline form of atorvastatin/WARNER-LAMBERT COMPANY LLC) of 25.02.2009
- European Case Law Identifier
- ECLI:EP:BA:2009:T076406.20090225
- Date of decision
- 25 February 2009
- Case number
- T 0764/06
- Petition for review of
- -
- Application number
- 96924368.2
- IPC class
- C07D 207/34
- Language of proceedings
- English
- Distribution
- Distributed to board chairmen (C)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Crystalline R-(R*,R*)-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-(phenylamino)carbonyl-1H-pyrrole-1-heptanoic acid hemi calcium salt (atorvastatin)
- Applicant name
- Warner-Lambert Company LLC
- Opponent name
- Teva Pharmaceutical Industries Ltd.
LEK Pharmaceutical and Chemical Company d.d. - Board
- 3.3.01
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 100(c) 1973European Patent Convention Art 113(1) 1973European Patent Convention Art 114(2) 1973European Patent Convention Art 123(2)European Patent Convention R 55(c) 1973European Patent Convention R 76(c)Rules of procedure of the Boards of Appeal Art 13(1)Rules of procedure of the Boards of Appeal Art 13(3)
- Keywords
- Admissibility of allegedly new ground of opposition (yes)
Added matter (yes) - Omission of an essential feature
Late-filed request (not admitted) - Catchword
- -
ORDER
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The patent is revoked.